Maternal hypothyroidism impairs fetal growth in the rat, but the mechanisms by which this occurs are unknown. Since the fetus derives its glucose supply from the mother, and maternal thyroidectomy may disturb maternal and placental glucose metabolism, we postulated that maternal and/or placental glucose metabolic compromise may contribute to fetal growth retardation in hypothyroid dams. Feto-placental growth, tissue glycogen stores and glucose levels in sera and amniotic fluid were determined in rat dams partially thyroidectomized (TX) before pregnancy and in euthyroid controls. Fetal body weight at 16, 19 and 21 days gestation (d.g.) was related to pre-mating maternal serum total thyroxine (TT 4 ) levels; permanent fetal growth retardation occurred in severely (TX s ; pre-mating maternal serum TT 4 c16·19 nM) -but not in moderately (TX m ) -hypothyroid dams. In TX s dams, glycogen concentration was elevated in maternal liver and in the fetal side of the placenta at 16 and 19 d.g., and in the maternal side of the placenta at 19 and 21 d.g., despite maternal euglycemia. In contrast, fetal liver glycogen concentration was deficient in TX m dams at 19 d.g. and in TX s dams at 19 and 21 d.g., and fetal hypoglycemia occurred in TX s dams at 21 d.g. Multiple regression analyses indicate that these fetal deficits are strongly associated with the retardation in fetal growth, while the elevated maternal liver and placental glycogen concentrations have no impact on fetal growth near term. The mechanisms by which severe maternal hypothyroidism permanently retards rat fetal growth remain to be determined.
Introduction
Maternal hypothyroidism influences feto-placental growth in rats, though the outcome depends on the timing of thyroidectomy in relation to conception and the degree of hypothyroidism. Thyroidectomy of rats before pregnancy has no effect on placental growth, but retards fetal growth, either transiently in moderately hypothyroid dams (Pickard et al. 1999) or permanently in severely hypothyroid dams (Morreale de Escobar et al. 1985 , Leonard et al. 1999 . In contrast, induction of moderate or severe maternal hypothyroidism soon after conception permanently retards placental and fetal growth (Porterfield et al. 1975 , Bonet & Herrera 1988 , Hendrich & Porterfield 1992 .
The mechanisms by which maternal thyroid status regulates fetal development are poorly understood. Direct action is possible, since materno-fetal thyroxine (T 4 ) transfer occurs in rat pregnancy, and fetal tissues express 5 -deiodinases and nuclear 3,5,3 -tri-iodothyronine (T 3 ) receptors (TR) (Porterfield & Hendrich 1993 , Pickard et al. 1997 , Morreale de Escobar et al. 2000 . The placenta also accumulates and metabolizes maternal T 4 and T 3 (Calvo et al. 1992 ) and expresses TR (Leonard et al. 2001) ; thus maternal thyroid hormone may regulate fetal development via effects on the placenta. Finally, other indirect mechanisms involving maternal tissues (Bonet & Herrera 1988 , Hendrich & Porterfield 1992 ) may be influential.
In dams made hypothyroid soon after conception, maternal metabolic compromise occurs (Bonet & Herrera 1988) which, together with reduced placental size, may restrict the provision of nutrients to the fetus, resulting in permanent fetal growth retardation. Whether dams made hypothyroid before pregnancy also suffer metabolic compromise is unknown. Although placental size is normal in the latter model, moderate maternal hypothyroidism compromises placental expression of glucose transporter (GLUT) protein isoforms (Pickard et al. 1999) . Furthermore, T 3 administration to rat dams during late pregnancy depletes placental glycogen stores (Shafrir et al. 1994) . Thus maternal thyroid status may regulate placental glycogen homeostasis and glucose transport and hence the supply of maternal glucose to the fetus. Since glucose serves as the primary fetal growth substrate, and the rat fetus is incapable of gluconeogenesis (Jones & Rolph 1985 , Girard et al. 1992 , we postulate that in dams made hypothyroid before pregnancy, permanent fetal growth retardation occurs as a consequence of disturbances in maternal and placental glycogen storage and hence glucose supply to the fetus (i.e. maternal and/or placental glucose metabolic compromise).
To test this hypothesis, we first examined the relationship between pre-mating maternal thyroid status and fetal body weight in partially thyroidectomized (TX group) and euthyroid rat dam pregnancies, and exploited the relationship near term to assign TX dam pregnancies at all stages of gestation to severely hypothyroid (TX s ; permanently growth-retarded) and more moderately hypothyroid (TX m ) groups. We then examined whether moderate and severe maternal hypothyroidism influences placental, maternal liver and fetal liver glycogen stores, as well as maternal and fetal glycemic status. Finally, we addressed whether compromise in maternal liver and placental glycogen concentrations contributes to permanent fetal growth retardation in TX dams.
Materials and Methods

Materials
All enzymes and fine chemicals were from Sigma-Aldrich Company Limited (Gillingham, Dorset, UK). The total T 4 (TT 4 ) RIA kit was from NETRIA (London, UK) and the total T 3 (TT 3 ) RIA kit from BM Browne (UK) Limited (Reading, Berks, UK).
Animal model
Sprague-Dawley female rats (proven breeders) were partially thyroidectomized by surgical removal of the lower one-half to two-thirds of each lobe, sparing the parathyroids, and allowed to recover for at least 2 weeks. Circulating TT 4 levels were determined and the animals mated overnight with normal males; the morning of appearance of a vaginal plug was designated day 0 of pregnancy. Normal (N group) females served as the control group. Animals were maintained in the local animal house facilities at 22 C on a cycle of 14 h light : 10 h darkness, and allowed free access to a standard small laboratory animal diet and water. The water of the TX group was supplemented with 0·1% (w/v) calcium lactate throughout.
Animals were stunned and killed by cervical dislocation at 16, 19 and 21 days gestation (d.g.); fetal thyroid hormone secretion occurs from 17·5 d.g. (Morreale de Escobar et al. 1985) and parturition at 22 d.g. Maternal blood was collected by cardiac puncture and the uterine horns were removed to ice. Fetuses and placentae were isolated and weighed, then fetal tissues were dissected and weighed. Tissue pools (from d three fetuses) were immediately frozen on dry ice and stored at 20 C until assay.
Samples were collected from 17 different batches of animals. In the light of initial findings, the tissue collection protocol was modified for the latter seven batches to include maternal liver (left lateral lobe), amniotic fluid and fetal blood; placental discs were also separated into maternal (junctional zone) and fetal (labyrinth) sides.
All experimental procedures complied with the Animal (Scientific Procedures) Act 1986 of the United Kingdom.
Glycogen and glucose determination
Liver and placental samples were deproteinized by homogenization with 5 volumes ice-cold 0·6 M perchloric acid, and glycogen was determined by a standard procedure, employing fungal glucoamylase for hydrolysis (Keppler & Decker 1984) . A rabbit liver glycogen preparation (0·45 M) was included with each batch of samples to verify complete hydrolysis.
Glucose was determined in neutralized tissue homogenates and hydrolysates, sera and amniotic fluid using a standard spectrophotometric procedure with hexokinase and glucose 6-phosphate dehydrogenase (Keppler & Decker 1984) ; glucose standards (10-250 nmol) were included in each assay. Glycogen concentrations, expressed as µmol glucose/g tissue wet weight, were corrected for endogenous glucose (Keppler & Decker 1984) .
Thyroid hormone determination
Levels of TT 4 and TT 3 were determined in maternal serum by RIA. Inter-and intra-assay coefficients of variance were, respectively, 5·8 and 4·5% for TT 4 , and 5·7 and 3·3% for TT 3 .
Statistical analysis
Data from N and TX dam pregnancies were compared by one-way ANOVA; Fisher's protected least significance differences (PLSD) were determined for post hoc analysis. Homogeneity of variance for all groups was assessed using Bartlett's test for samples of unequal size and, where necessary, a square root or log e transformation was applied before analysis. For simple and multiple regression analyses, linearity of the data was determined by a runs test. Statistical analyses were performed using Statview 1·03 (Abacus Concepts, Inc., Berkeley, CA, USA) and GraphPad Prism 2·0c (GraphPad Software, Inc., San Diego, CA, USA); statistical significance was defined as P<0·05. Results are expressed as means S.E.M.
Results
Relationship between fetal body weight and pre-mating maternal serum TT 4 levels
Previous studies with the TX dam model have shown that in moderate maternal hypothyroidism, fetal body weight is reduced at 16 d.g. but normal at 21 d.g. (Pickard et al. 1999) , whereas in severe maternal hypothyroidism, late fetal growth is also retarded (Leonard et al. 1999) . Indeed in the present study, fetal body weights at 16-21 d.g. were found to vary with pre-mating maternal serum TT 4 levels, in a manner consistent with a hyperbolic relationship at each age ( Fig. 1 left panel (Fig. 1 right panel) . The relationship at 21 d.g. allowed statistical determination of the pre-mating maternal serum TT 4 level which would be expected to give rise to permanently growth-retarded fetuses. The 99% confidence interval of the y-axis intercept in the reciprocal plot was calculated (Altman & Gardner 1989) , and the lower limit extrapolated to the upper 99% confidence limit of the regression line, corresponding to a pre-mating TT 4 level of 16·19 nM ( Fig. 1 right panel) . This value was used to assign TX dams at all stages of gestation to moderately (TX m dams; pre-mating TT 4 c16·19 nM) and severely (TX s dams; pre-mating TT 4 =16·19 nM) hypothyroid groups, in order to better explore how severe maternal hypothyroidism retards late fetal growth.
Maternal thyroid status
Pre-mating maternal serum TT 4 levels were reduced in TX m and TX s dams compared with N dams, and in TX s dams compared with TX m dams (Table 1) , as expected. Within each treatment group, pre-mating TT 4 levels were similar irrespective of the stage of gestation studied.
Maternal serum TT 4 levels were reduced in both TX dam groups relative to N dams at all ages during pregnancy, and in TX s dams relative to TX m dams at 16 and 19 d.g. (Table 1) . Maternal serum TT 4 levels at each stage Figure 1 Relationship between fetal body weight near term and pre-mating maternal serum TT 4 level. Data derived from N (•; n=20) and TX (; n=34) dam pregnancies at 21 d.g. were consistent with a hyperbolic relationship (left panel). Regression of fetal body weight on the reciprocal of pre-mating maternal serum TT 4 (right panel) yielded a linear relationship (y=-9·042x+5·088; r=-0·547; P<0·001). The 99% confidence interval of the intercept at 5·09 g was calculated, and the grey line indicates extrapolation of the lower limit of 4·73 g across to the upper 99% confidence limit of the regression line. This corresponds to a pre-mating maternal serum TT 4 level of 16·19 nM, at or below which permanent fetal growth retardation is considered to occur. 
Litter size and feto-placental growth
The number of fetuses carried by TX m and TX s dams was reduced at all ages relative to N dams ( In N dams, the weight of the maternal side of the placenta remained constant over the period studied, whereas that of the fetal side more than doubled (Table 2) , as expected (Davies & Glasser 1968) , so that near term the fetal side accounted for two-thirds of total placental mass, in keeping with published data (Ne'eman et al. 1987) . The weight of the placenta, either whole or after separation into maternal and fetal sides, was normal in all TX dams (Table 2) .
Tissue glycogen levels
For all tissues from euthyroid pregnancies, glycogen concentrations and their ontogeny agreed with published data (Gruppuso & Brautigan 1989 , Shafrir & Barash 1991 .
Fetal liver glycogen concentration and content were low in N dams at 16 d.g., then increased markedly as gestation progressed (Table 3) The placental glycogen concentration also fell between 16 and 21 d.g. in N dams (Fig. 2) . This decline was more pronounced between 16 and 19 d.g. in the maternal side than the fetal side, though glycogen concentration was higher in the former side at all stages, as expected (Ne'eman et al. 1987) . Relative to N dams, glycogen concentration in total and maternal placenta from TX s dams was elevated to a similar extent at 19 d.g. and at 21 d.g., whereas it was elevated in fetal placenta from TX s dams at 16 and 19 d.g. (Fig. 2) . Glycogen content showed a similar ontogeny to glycogen concentration in normal total and maternal placenta, and was similarly influenced by maternal thyroidectomy (Fig. 2) . In contrast, glycogen content in the fetal side increased (P<0·05) slightly between 16 and 19 d.g. in N dams, as the mass of this tissue doubled (Table 2) ; treatment-associated changes were limited to an elevation in TX s dams at 19 d.g. (Fig. 2) .
Regression of the maternal placental glycogen concentration at 19 or 21 d.g. on the reciprocal of the pre-mating maternal serum TT 4 level revealed significant relationships (Fig. 3) of comparable slope but different (P<0·001) elevation. The fetal placental glycogen concentration at 19 d.g. only was related to the reciprocal of the pre-mating maternal serum TT 4 level, albeit the data at 16 d.g. were highly scattered (Fig. 3) . Since fetal size was reduced in TX dams, fetal demands on placental metabolic stores may be reduced, and this may in part explain the elevated maternal and fetal placental glycogen concentrations. However only the maternal placental glycogen concentration at 21 d.g. was related to fetal body weight (r=-0·518; P=0·006; n=27). Furthermore, multiple regression analysis of these data against the reciprocal of pre-mating maternal serum TT 4 and fetal body weight yielded a significant relationship (R=0·598; P=0·005; n=27), but only the relationship between the maternal placental glycogen concentration and the reciprocal of pre-mating maternal serum TT 4 tended towards statistical significance (P=0·080). Reduced fetal size is therefore unlikely to account for elevated placental glycogen stores in TX s dams.
Serum and amniotic fluid glucose concentrations
The maternal serum glucose concentration was normal in TX dams at all stages (Table 4) . Fetal serum glucose at 16 and 21 d.g. displayed hyperbolic relationships with premating maternal serum TT 4 (Fig. 4) , but levels were only reduced in TX s dams at 21 d.g. (Table 4 ). The amniotic fluid glucose concentration at 16 d.g. also displayed a hyperbolic relationship with pre-mating maternal serum TT 4 (Fig. 4) and was reduced in TX m and TX s dams at this stage only (Table 4) .
At 16 d.g., amniotic fluid glucose was related to fetal body weight (r=0·518; P=0·007; n=26), as was the case at 21 d.g. for fetal serum glucose (r=0·599; P<0·001; n=37). Upon multiple regression analysis, fetal serum glucose at 21 d.g. (R=0·599; P<0·001) was related to fetal body weight (P=0·001) but no longer to the reciprocal of pre-mating maternal serum TT 4 , whereas amniotic fluid glucose at 16 d.g. (R=0·606; P=0·005) failed to show a significant relationship with either fetal body weight or the reciprocal of pre-mating maternal serum TT 4 (albeit P=0·077 and 0·071 respectively). Thus, in TX s dams near term at least, the apparent fetal hypoglycemia is likely to arise secondary to fetal growth retardation, since the fetal serum glucose concentration appears normal for fetal body weight, albeit both parameters are depressed in TX s dams relative to N dams.
Fetal growth retardation near term is unrelated to maternal and placental glucose metabolic compromise
The onset of fetal thyroid activity rapidly normalizes fetal tissue thyroid hormone pools in overtly hypothyroid rat dams (Ruiz de Ona et al. 1991) , so that persisting fetal hypothyroidism cannot explain the pronounced fetal body weight deficits in TX s dams near term. In this study, the observation in TX dams that fetal serum glucose levels appear normal for fetal body weight, and that maternal serum glucose concentrations were normal, further suggests that neither placental nor maternal glucose metabolic compromise contribute to fetal growth retardation in hypothyroid pregnancies near term. To test this proposal, a subset (n=17) of N and TX dam pregnancies at 21 d.g. was selected for which fetal body weight, litter size, pre-mating maternal serum TT 4 , maternal serum glucose, maternal hepatic glycogen and maternal placental glycogen concentrations were all characterized. Multiple regression analysis was performed using a stepwise procedure with fetal body weight as the dependent variable and all other parameters (the reciprocal of pre-mating maternal serum TT 4 was used for this analysis) as predictor variables. This resulted in the selection of a one-factor multiple regression model (R=0·671; P=0·003) in which fetal body weight was related only to the reciprocal of premating maternal serum TT 4 . Consequently, maternal and/or placental glucose metabolic compromise are unlikely to contribute to fetal growth retardation in hypothyroid pregnancies near term.
Discussion
We have studied rat dams thyroidectomized several weeks before pregnancy and shown that the impact on fetal growth varies according to the severity of maternal hypothyroidism, the stage of pregnancy and the fetal tissue under study. Moderate hypothyroidism (pre-mating maternal serum TT 4 >16·19 nM) was associated with transient reductions in fetal body and brain weights before the onset of fetal thyroid hormone secretion, and a reduction in fetal liver weight near term. In contrast, more severe hypothyroidism was associated with deficits in fetal body, brain and liver weights which were more pronounced and asymmetrical near term; fetal liver weight was more markedly reduced than body weight, whereas some brain growth-sparing occurred. These findings are in agreement with earlier studies of dams made hypothyroid before pregnancy (Morreale de Escobar et al. 1985 , Pickard et al. 1999 . We hypothesized that maternal and placental glycogen storage and glucose supply to the fetus are disturbed in TX dams, and that such glucose metabolic compromise contributes to fetal growth retardation, especially near term, when the fetal demand for glucose is high.
Thyroidectomy of rat dams on the day of conception impairs the build-up of the maternal metabolic stores, including liver glycogen, required to support late fetal growth. Maternal hypoglycemia may (Bonet & Herrera 1991) or may not (Porterfield et al. 1975) ensue, however fetal and placental growth is severely retarded in late gestation (Bonet & Herrera 1988 , Hendrich & Porterfield 1992 . In contrast, in the present study, maternal liver glycogen concentration was elevated in TX s dams at 16 and 19 d.g. This increase was partly related to pre-mating maternal thyroid status, in keeping with studies in thyroidectomized non-pregnant adult animals (Tata et al. 1963 , Castro & Herrera 1973 and was also related to litter size, which was depressed in TX dams. Importantly, maternal euglycemia was maintained in TX s dams, perhaps due to the establishment of compensatory metabolic mechanisms before exposure to the stress of pregnancy, and to the depression in litter size and thus feto-placental metabolic demands.
Rat placental glycogen stores are depleted by chronic T 3 administration in late gestation (Shafrir et al. 1994) . In agreement with this finding, placental glycogen concentration was elevated in TX s dams: at 19 and 21 d.g. in the maternal side, but at 16 and 19 d.g. in the fetal side, independent of reduced fetal size. These differences may be cell specific, since glycogen is predominantly found in glycogen cells and syncytiotrophoblasts on the maternal and fetal sides respectively (Davies & Glasser 1968 , Ne'eman et al. 1987 . Placental thyroid hormone homeostasis may also be influential since, in hypothyroid dams, the T 3 :T 4 ratio is increased on the maternal side, whereas fetal thyroid function compensates thyroid hormone deficits on the fetal side (Ruiz de Ona et al. 1991 , Calvo et al. 1992 . Thyroidectomy of pregnant dams, in contrast, causes no elevation in term placental glycogen levels (Porterfield et al. 1975) , perhaps due to the attendant severe maternal metabolic and placental growth compromise.
At 16 d.g., fetal serum and amniotic fluid glucose levels exhibited similar dependencies on pre-mating maternal serum TT 4 , but only the amniotic fluid glucose level was reduced in TX m and TX s dams. Previously, fetal serum glucose was found to be depressed in moderately hypothyroid dams at 16 d.g. (Pickard et al. 1999) . The reason for this discrepancy is unclear, but current findings indicate that fetuses of TX dams exhibit at worst only mild hypoglycemia prior to the onset of fetal thyroid function. At 19 d.g., fetal serum and amniotic fluid glucose concentrations had normalized in TX m and TX s dams, but fetal liver glycogen stores were deficient. At 21 d.g., these normalized in TX m dams, whereas they remained deficient in TX s dams, and this was accompanied by severe fetal hypoglycemia. Deficient liver glycogen storage coupled with hypoglycemia is also characteristic of term fetuses from dams thyroidectomized soon after conception (Porterfield et al. 1975 ). In our model at least, such effects were strongly related to fetal body weight, pre-mating maternal serum TT 4 having no residual influence.
The relationship between fetal body weight and serum glucose may indicate that fetal body weight is strongly constrained by fetal serum glucose or, alternatively, that the ontogenic increase in fetal serum glucose concentration is dependent on some uncharacterized factor related to fetal growth. The data analysis presented here cannot discriminate unambiguously between these possibilities, since the statistical approach used does not allow mechanistic conclusions to be made definitively. The second possibility is perhaps more likely to occur in this model however, since the maternal serum glucose concentration and placental expression of GLUT protein isoforms (Pickard et al. 1999) are normal in TX dams near term, albeit materno-fetal glucose transport remains to be determined. Thus fetal growth retardation in TX s dams at this stage is unlikely to be due to impaired fetal glucose availability or maternal/placental glucose metabolic compromise. Indeed, maternal liver and placental glycogen concentrations and maternal serum glucose were all rejected as predictor variables for fetal body weight at 21 d.g. in the multiple regression analysis. This was not unexpected for maternal liver glycogen and serum glucose levels, since both were normal in TX s dams at 21 d.g. A role for maternal glucose metabolic compromise in fetal growth retardation in TX s dams at earlier stages of pregnancy is also unlikely, since fetal body weight at 16 and 19 d.g. was unrelated to maternal serum glucose (data not shown) and hepatic glycogen concentrations.
More general disturbances in maternal metabolism may contribute to fetal growth retardation in TX dams, since hypothyroidism during pregnancy impairs maternal body weight gain (Bonet & Herrera 1988 , Versloot et al. 1998 ). This did not appear to occur in the present study, since although maternal carcass weight (after removal of uteri) tended to be slightly lower (by 10%) for TX m and TX s dams compared with N dams at 16 and 21 d.g. (data not shown), it had no influence on fetal growth in single or multiple regression analyses with other relevant factors (data not shown). Furthermore, maternal nutritional restriction depresses placental weight and glycogen stores (Woodall et al. 1996 , Rudge et al. 1999 , whereas the TX s dams in the present study exhibited normal placental weight and elevated placental glycogen stores.
In conclusion, fetal body weight during late gestation exhibits a hyperbolic relationship with pre-mating maternal serum TT 4 levels in rat dams made hypothyroid before conception; permanent fetal growth retardation occurring only in severely hypothyroid dams. In such pregnancies, excessive glycogen storage occurs in the maternal liver and the placenta from before the onset of fetal thyroid function, whereas fetal liver glycogen stores and serum glucose levels are depressed near term. These fetal deficits appear due to the attendant fetal growth retardation, and neither maternal nor placental glucose metabolic compromise are likely to contribute to this process near term. The mechanisms by which severe maternal hypothyroidism retard fetal growth near term remain to be determined.
